Method for palliation of pain in human bone cancer using therape

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

534 10, 600 1, 600 3, A61K 5104, C07F 500, A61N 500

Patent

active

058536957

ABSTRACT:
The invention provides a method for the palliation of bone pain due to cancer by the administration of a unique dosage of a tin-117m (Sn-117m) stannic chelate complex in a pharmaceutically acceptable composition. In addition, the invention provides a method for simultaneous palliation of bone pain and radiotherapy in cancer patients using compositions containing Sn-117m chelates. The invention also provides a method for palliating bone pain in cancer patients using Sn-117m-containing compositions and monitoring patient status by imaging the distribution of the Sn-117m in the patients. Also provided are pharmaceutically acceptable compositions containing Sn-117m chelate complexes for the palliation of bone pain in cancer patients.

REFERENCES:
patent: 4533541 (1985-08-01), Srivastava et al.
Harold L. Atkins et al., "Biodistribution of Sn-117m(4+) DTPA for Palliative Therapy of Painful Osseous Metastases," Radiology, 186, 279-283 Jan. 1993.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for palliation of pain in human bone cancer using therape does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for palliation of pain in human bone cancer using therape, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for palliation of pain in human bone cancer using therape will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1421315

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.